Bragg Financial Advisors, Inc Gilead Sciences, Inc. Transaction History

Bragg Financial Advisors, Inc

$2.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $74,721 - $107,274	-1,199 Reduced 31.74%	2,578 $221,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $137,120 - $156,627	-2,303 Reduced 37.88%	3,777 $233,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $133,679 - $150,563	-2,316 Reduced 27.58%	6,080 $376,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $280,680 - $351,722	-4,846 Reduced 36.6%	8,396 $499,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $137,275 - $148,104	-2,028 Reduced 13.28%	13,242 $925,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $409,508 - $447,446	-6,452 Reduced 29.7%	15,270 $1.05 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $193,560 - $220,851	-3,226 Reduced 12.93%	21,722 $1.4 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $4,078 - $4,647	-72 Reduced 0.29%	24,948 $1.45 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $6,458 - $8,120	104 Added 0.42%	25,020 $1.58 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $87,676 - $101,808	1,212 Added 5.11%	24,916 $1.92 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $11,022 - $14,118	176 Added 0.75%	23,704 $1.77 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $177,958 - $195,748	-2,888 Reduced 10.93%	23,528 $1.53 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $25,129 - $27,738	-402 Reduced 1.5%	26,416 $1.67 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $45,165 - $50,647	730 Added 2.8%	26,818 $1.81 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $119,870 - $134,285	1,917 Added 7.93%	26,088 $1.7 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $95,168 - $124,188	1,572 Added 6.96%	24,171 $1.51 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $24,948 - $27,622	350 Added 1.57%	22,599 $1.75 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $131,122 - $152,949	2,021 Added 9.99%	22,249 $1.58 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $19,375 - $23,620	-266 Reduced 1.3%	20,228 $1.53 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $103,096 - $121,020	-1,449 Reduced 6.6%	20,494 $1.47 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.58 Million - $1.88 Million	21,943	21,943 $1.78 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bragg Financial Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bragg Financial Advisors, Inc with notifications on news.

Account